Overview

The Effects of Methylphenidate and Non-invasive Brain Stimulation on Inhibitory Control in Children With ADHD

Status:
Recruiting
Trial end date:
2022-11-02
Target enrollment:
0
Participant gender:
All
Summary
The aim of this study is comparing the effects of non-pharmacological intervention (transcranial Direct Current Stimulation, tDCS) with those of drug (methylphenidate, MPH) administration in children and adolescents with ADHD. The investigators hypothesized that tDCS would improve inhibitory control and visuo-spatial working memory as well as MPH.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Bambino Gesù Hospital and Research Institute
Treatments:
Methylphenidate
Criteria
Criteria: Inclusion Criteria:

- Patients must receive a Diagnostic and Statistical Manual of Mental Disorders (DSM-5)
oriented diagnosis of ADHD and need drug treatment for the severity of symptoms;

- Intelligent Quotient (IQ) > 85;

Exclusion Criteria:

- Presence of Autism Spectrum Disorders;

- Presence of Mood Disorders;

- Previous/current diagnosis of neurological conditions (i.e. epilepsy,
neurodegenerative diseases);

- Presence of Genetic Syndromes;

- Presence of basal medical conditions (i.e. heart, kidney or liver diseases) which may
exclude the possibility to administer MPH.